Engineered immune cells take on lupus kidney damage in new trial
NCT ID NCT07364396
First seen Jan 29, 2026 · Last updated May 01, 2026 · Updated 16 times
Summary
This early-phase trial tests a new treatment called CRC01 for people with severe lupus that has damaged their kidneys. CRC01 is made from a patient's own immune cells, which are modified in a lab to target and calm the overactive immune system. The study will enroll 39 adults to see if the therapy is safe and can improve kidney function and reduce lupus symptoms over one year.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUPUS NEPHRITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.